+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pneumococcal Testing Market - Global Forecast 2026-2032- Product Image
Pneumococcal Testing Market - Global Forecast 2026-2032- Product Image
New

Pneumococcal Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336733
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pneumococcal testing market is evolving rapidly, responding to clinical imperatives for more precise and timely diagnosis, advanced surveillance, and robust supply strategies. Modern decision-makers are challenged to align emerging technologies and operational solutions with shifting global health needs, ensuring diagnostics deliver value across diverse clinical and public health contexts.

Market Snapshot

The Pneumococcal Testing Market expanded from USD 2.85 billion in 2025 to USD 3.05 billion in 2026 and is projected to reach USD 4.94 billion by 2032, reflecting a CAGR of 8.16%. This performance highlights continued demand for sensitive, specific, and scalable diagnostic platforms. Growth is underpinned by rising clinical complexity, serotype evolution following immunization programs, and ongoing efforts to combat antimicrobial resistance. Improved adoption of molecular and sequencing-based diagnostics is driving operational shifts in key markets worldwide.

Scope & Segmentation

  • Test Types:
    • Culture-based methods offer confirmation and susceptibility testing.
    • Molecular assays deliver multiplexing and high sensitivity.
    • Serological assays provide immunogenicity assessment and rapid screening.
  • Technologies:
    • ELISA platforms for detailed immunological evaluation.
    • Immunochromatographic methods for decentralized applications.
    • Next-generation sequencing and PCR (multiplex, digital, real-time) for nuanced diagnostic and surveillance tasks.
  • Clinical Applications:
    • Rapid disease diagnosis, carrier screening, serotype surveillance, and vaccine evaluation.
  • End-User Settings:
    • Clinics and outpatient centers require user-friendly, rapid-turnaround tests.
    • Hospitals balance high-volume capability with confirmatory approaches.
    • Public health and reference labs focus on complex surveillance and specialized analysis.
  • Distribution Channels:
    • Direct sales and online manufacturer portals cater to high-value accounts.
    • Distributors and e-commerce platforms extend geographic availability and streamline supply management.
  • Regions:
    • Americas demonstrate strong laboratory infrastructure and integration of public-private initiatives.
    • Europe, Middle East, and Africa present varying laboratory capabilities and regulatory requirements.
    • Asia-Pacific features rapid technology adoption in urban centers and dual market structures to address both centralized and decentralized needs.

Key Takeaways

  • Molecular innovation, including multiplex and digital PCR, enables precise differential diagnosis and simultaneous detection of multiple targets, helping distinguish invasive disease from colonization.
  • Sequencing technologies now support applied surveillance and real-time serotype monitoring, driving the integration of clinical and public health data systems.
  • Serological and culture-based methods maintain relevance in settings requiring accessible, cost-effective confirmation or immunogenicity evaluation, particularly where resources and laboratory infrastructure are variable.
  • Supply chain resilience is a top operational priority. Strategic supplier diversification and nearshoring strategies help mitigate input cost volatility.
  • Interoperable data workflows and standardized reporting are essential for harmonized surveillance and broader diagnostic impact.
  • Stakeholder partnerships, including manufacturer-lab alliances and public sector collaborations, facilitate market access and expedite real-world validation.

Pneumococcal Testing Market Tariff Impact

Tariff policy adjustments instituted in 2025 have increased sourcing pressures across diagnostic supply chains. Laboratories and manufacturers have adapted strategies to address higher input costs by diversifying suppliers, implementing contingency inventory measures, and qualifying alternate production sites. These adjustments are promoting a renewed focus on supply security and regulatory alignment. Collaborative procurement and cost transparency are recognized as crucial elements of sustainable diagnostics deployment.

Methodology & Data Sources

This report integrates a mixed-methods approach: primary research involved structured interviews with clinical, laboratory, and supply specialists; secondary sources included peer-reviewed literature, technical papers, and regulatory documents. Expert validation and data triangulation strengthened reliability, while quality controls encompassed credential verification, anonymized data aggregation, and iterative expert review.

Why This Report Matters

  • Enables market leaders to anticipate technology trends and adapt product strategies for evolving diagnostic priorities.
  • Informs supply chain, procurement, and resilience planning with actionable, region-specific insights.
  • Equips commercial teams and public health stakeholders with evidence-based recommendations to accelerate strategic adoption and impact.

Conclusion

Effective pneumococcal testing strategies now rely on aligning advanced diagnostic capabilities with regional infrastructure, regulatory environments, and collaborative partnerships. Focusing on interoperability, operational resilience, and evidence-based adoption enables organizations to drive meaningful improvements in patient outcomes and public health.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pneumococcal Testing Market, by Type Of Test
8.1. Culture Based
8.1.1. Automated Culture
8.1.2. Conventional Culture
8.2. Molecular
8.2.1. Digital PCR
8.2.2. Multiplex PCR
8.2.3. Real Time PCR
8.3. Serological
8.3.1. Elisa
8.3.2. Rapid Immunoassay
9. Pneumococcal Testing Market, by Technology
9.1. Elisa
9.1.1. Indirect Elisa
9.1.2. Sandwich Elisa
9.2. Immunochromatographic Test
9.2.1. Dot Blot
9.2.2. Lateral Flow Assay
9.3. Next-Generation Sequencing
9.3.1. Illumina Platform
9.3.2. Ion Torrent
9.4. Pcr Assay
9.4.1. Digital PCR
9.4.2. Multiplex PCR
9.4.3. Real Time PCR
10. Pneumococcal Testing Market, by Application
10.1. Carrier Screening
10.1.1. Nasopharyngeal Screening
10.1.2. Oropharyngeal Screening
10.2. Diagnosis
10.2.1. Community Acquired Pneumonia
10.2.2. Meningitis
10.2.3. Otitis Media
10.3. Surveillance
10.3.1. Antibiotic Resistance Monitoring
10.3.2. Serotype Distribution
10.4. Vaccine Evaluation
10.4.1. PostMarketing Surveillance
10.4.2. PreClinical Trials
11. Pneumococcal Testing Market, by End User
11.1. Clinics
11.1.1. Community Health Centers
11.1.2. Outpatient Clinics
11.2. Hospitals
11.2.1. Large Hospitals
11.2.2. Small Hospitals
11.3. Public Health Labs
11.3.1. Local Public Health Labs
11.3.2. State Public Health Labs
11.4. Reference Labs
11.4.1. National Reference Labs
11.4.2. Regional Reference Labs
12. Pneumococcal Testing Market, by Distribution Channel
12.1. Direct Sales
12.1.1. Online Direct
12.1.2. Specialty Sales Team
12.2. Distributors
12.2.1. Local Distributors
12.2.2. National Distributors
12.3. Online
12.3.1. Ecommerce Platforms
12.3.2. Manufacturer Portals
13. Pneumococcal Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Pneumococcal Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Pneumococcal Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Pneumococcal Testing Market
17. China Pneumococcal Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Becton, Dickinson and Company
18.7. Bio-Rad Laboratories, Inc.
18.8. bioMérieux SA
18.9. F. Hoffmann-La Roche Ltd
18.10. Hologic, Inc.
18.11. Meridian Bioscience Inc.
18.12. QIAGEN N.V.
18.13. Seegene Inc.
18.14. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PNEUMOCOCCAL TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AUTOMATED CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AUTOMATED CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY AUTOMATED CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CONVENTIONAL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY INDIRECT ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY INDIRECT ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SANDWICH ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SANDWICH ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DOT BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DOT BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DOT BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ILLUMINA PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ILLUMINA PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ILLUMINA PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ION TORRENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NASOPHARYNGEAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NASOPHARYNGEAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NASOPHARYNGEAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OROPHARYNGEAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OROPHARYNGEAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OROPHARYNGEAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MENINGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MENINGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OTITIS MEDIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OTITIS MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANTIBIOTIC RESISTANCE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANTIBIOTIC RESISTANCE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ANTIBIOTIC RESISTANCE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROTYPE DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROTYPE DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROTYPE DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POSTMARKETING SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POSTMARKETING SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY POSTMARKETING SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRECLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRECLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PRECLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LARGE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LARGE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SMALL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SMALL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL PUBLIC HEALTH LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL PUBLIC HEALTH LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL PUBLIC HEALTH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE PUBLIC HEALTH LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE PUBLIC HEALTH LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY STATE PUBLIC HEALTH LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL REFERENCE LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL REFERENCE LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL REFERENCE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGIONAL REFERENCE LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGIONAL REFERENCE LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGIONAL REFERENCE LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE DIRECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE DIRECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE DIRECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SPECIALTY SALES TEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SPECIALTY SALES TEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY SPECIALTY SALES TEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY ECOMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MANUFACTURER PORTALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MANUFACTURER PORTALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY MANUFACTURER PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL PNEUMOCOCCAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 219. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 220. AMERICAS PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 260. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 262. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL TESTING MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
TABLE 293. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY TYPE OF TEST, 2018-2032 (USD MILLION)
TABLE 295. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY CULTURE BASED, 2018-2032 (USD MILLION)
TABLE 296. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 297. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY SEROLOGICAL, 2018-2032 (USD MILLION)
TABLE 298. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY ELISA, 2018-2032 (USD MILLION)
TABLE 300. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, 2018-2032 (USD MILLION)
TABLE 301. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 302. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY PCR ASSAY, 2018-2032 (USD MILLION)
TABLE 303. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 304. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY CARRIER SCREENING, 2018-2032 (USD MILLION)
TABLE 305. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 306. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY SURVEILLANCE, 2018-2032 (USD MILLION)
TABLE 307. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY VACCINE EVALUATION, 2018-2032 (USD MILLION)
TABLE 308. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 310. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 311. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY PUBLIC HEALTH LABS, 2018-2032 (USD MILLION)
TABLE 312. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY REFERENCE LABS, 2018-2032 (USD MILLION)
TABLE 313. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 314. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
TABLE 315. EUROPE PNEUMOCOCCAL TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
TABLE 316.

Companies Mentioned

The key companies profiled in this Pneumococcal Testing market report include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • QIAGEN N.V.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.05 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.94 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides - Product Image

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides

  • Report
  • 606 Pages
  • Global
From
Canine Cancer Screening Market - Global Forecast 2026-2032 - Product Image

Canine Cancer Screening Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Ovarian Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Ovarian Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Plant Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Plant Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 248 Pages
  • Global
From
Norovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Norovirus Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 267 Pages
  • Global
From

About the Pneumococcal Test Market

The Pneumococcal Test is a diagnostic tool used to detect the presence of Streptococcus pneumoniae, a bacterium that can cause a range of illnesses, including pneumonia, meningitis, and sepsis. The test is typically performed on a sample of blood, sputum, or cerebrospinal fluid, and can be used to diagnose an infection, determine the severity of the infection, and monitor the effectiveness of treatment. The Pneumococcal Test market is a subset of the larger Diagnostics market, which includes a range of tests used to diagnose and monitor a variety of medical conditions. The Pneumococcal Test market is driven by the increasing prevalence of pneumococcal infections, as well as the need for accurate and timely diagnosis and treatment. Some companies in the Pneumococcal Test market include Abbott, Becton Dickinson, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.